Email this article 
PHARMACOLOGICAL SUPERVISION: THE EUROPEAN EXPERIENCE
- Authors: Gratsianskaya A.N.1, Gratsianskaya AN2
-
Affiliations:
- THE Russian State Medical University
- Issue: Vol 8, No 3 (2011)
- Pages: 65-67
- Section: Articles
- Submitted: 10.03.2020
- Published: 15.09.2011
- URL: https://rusalljournal.ru/raj/article/view/806
- DOI: https://doi.org/10.36691/RJA806
- ID: 806
Cite item
Open Access
Access granted
Subscription or Fee Access
Abstract
Keywords
About the authors
Anna Nikolaevna Gratsianskaya
Email: lusslv@yandex.ru
A N Gratsianskaya
THE Russian State Medical UniversityTHE Russian State Medical University
References
- WHO Policy Perspectives on Medicines - Pharmacovigilance: ensuring the safe use of medicines http://whqlibdoc.who. int/hq/2004/WHO_EDM_2004.8.pdf.
- http://teratology.org.
- http://www.who.int.
- Shakir SA.W. PEM in the UK. In: Mann R.D., Andrews E., editors. Pharmacovigilance. Chichester, UK: John Wiley & Sons Ltd. 2002.
- Volume IX of the rules governing Medicinal Products for Human and Veterinary Use in the EU. Version December 2001 [online]. Available from URL: http://www.pharmacos.eudra.org/.
- Mosley J.N.S. Risk Management. A European Regulatory Perspective. Drug Safety. 2004, v. 27 (8), p. 499-508.
Supplementary files
